Prot #CLT008-03: An Open-label Phase 2 Prospective, Randomized, Controlled Study of CLT-008 Myeloid Progenitor Cells As A Supportive Care Measure During Induction Chemotherapy For Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date1/13/151/13/18

Funding

  • SynteractHCR, Inc. (Prot #CLT008-03)
  • Cellerant Therapeutics, Inc. (Prot #CLT008-03)